Update: IV Fluid Shortage
FDA is aware of the shortage situation for intravenous (IV) solutions, particularly 0.9% sodium chloride injection (i.e., saline)
Calcium gluconate 10 percent Injections by Rx Formulations: Recall – Microbial Contamination
FDA notified healthcare professionals to follow up with patients who received calcium gluconate 10% injections made by Rx Formulations, Mesa, Ariz., between Nov. 7 and Dec. 11, 2013.
A Comparison of the Systems for the Identification of Postoperative Acute Kidney Injury in Pediatric Cardiac Patients
This study aimed to compare the three classifications for predicting AKI in pediatric patients undergoing cardiac operations.
Cardiopulmonary Bypass, Inflammation and How to Defy it: Focus on Pharmacological Interventions
One of the main untoward effects of CPB is systemic inflammation
Ischemia-Modified Albumin and Adenosine Plasma Concentrations are associated with Severe Systemic Inflammatory Response Syndrome after Cardiopulmonary Bypass
Adenosine plasma concentration and IMA concentration are associated with postoperative severe SIRS after CPB.
Association of Plasma Dilution with Cardiopulmonary Bypass-Associated Bleeding and Morbidity
Patient morbidity and likelihood of transfusion were associated with calculated plasma protein concentrations below 45% of baseline.
A Comparison Study of Haemolysis Production in Three Contemporary Centrifugal Pumps
This study demonstrated that all three pumps produced low levels of haemolysis and are suitable for use in a clinical environment.
Randomized Trials of PCIs versus CABG Surgery: Why Coronary Stenting should Remain the First Choice of Revascularization in Non-Diabetic Patients and why the Controversy is Still Present in Diabetics
The authors analyze these data to discuss the best therapeutic procedures for each patient.
Development of a New Selective Coronary Perfusion Cannula
We have examined the properties of a newly developed Kochi Medical School (KMS)-type cannula